vs
Side-by-side financial comparison of Douglas Elliman Inc. (DOUG) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Douglas Elliman Inc. is the larger business by last-quarter revenue ($245.4M vs $123.8M, roughly 2.0× NATURES SUNSHINE PRODUCTS INC). Douglas Elliman Inc. runs the higher net margin — 27.9% vs 3.3%, a 24.6% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 0.9%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-14.7M). Over the past eight quarters, Douglas Elliman Inc.'s revenue compounded faster (10.7% CAGR vs 5.6%).
Douglas Elliman Inc. is a leading U.S.-based residential real estate brokerage firm. It offers luxury property sales, rentals, property management, and advisory solutions, serving high-net-worth clients across key metro markets including New York, California, Florida, and Texas.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
DOUG vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $245.4M | $123.8M |
| Net Profit | $68.6M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 27.3% | 4.3% |
| Net Margin | 27.9% | 3.3% |
| Revenue YoY | 0.9% | 4.7% |
| Net Profit YoY | 1243.4% | 1379.4% |
| EPS (diluted) | $0.80 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $245.4M | $123.8M | ||
| Q3 25 | $262.8M | $128.3M | ||
| Q2 25 | $271.4M | $114.8M | ||
| Q1 25 | $253.4M | $113.2M | ||
| Q4 24 | $243.3M | $118.2M | ||
| Q3 24 | $266.3M | $114.6M | ||
| Q2 24 | $285.8M | $110.6M | ||
| Q1 24 | $200.2M | $111.0M |
| Q4 25 | $68.6M | $4.1M | ||
| Q3 25 | $-24.7M | $5.3M | ||
| Q2 25 | $-22.7M | $5.3M | ||
| Q1 25 | $-6.0M | $4.7M | ||
| Q4 24 | $-6.0M | $-321.0K | ||
| Q3 24 | $-27.2M | $4.3M | ||
| Q2 24 | $-1.7M | $1.3M | ||
| Q1 24 | $-41.5M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | 27.3% | 4.3% | ||
| Q3 25 | -4.1% | 7.0% | ||
| Q2 25 | -2.0% | 3.7% | ||
| Q1 25 | -2.1% | 5.4% | ||
| Q4 24 | -6.7% | 3.8% | ||
| Q3 24 | -2.8% | 4.6% | ||
| Q2 24 | -1.3% | 5.1% | ||
| Q1 24 | -20.7% | 4.2% |
| Q4 25 | 27.9% | 3.3% | ||
| Q3 25 | -9.4% | 4.2% | ||
| Q2 25 | -8.4% | 4.6% | ||
| Q1 25 | -2.4% | 4.2% | ||
| Q4 24 | -2.5% | -0.3% | ||
| Q3 24 | -10.2% | 3.8% | ||
| Q2 24 | -0.6% | 1.2% | ||
| Q1 24 | -20.7% | 2.1% |
| Q4 25 | $0.80 | $0.23 | ||
| Q3 25 | $-0.29 | $0.30 | ||
| Q2 25 | $-0.27 | $0.28 | ||
| Q1 25 | $-0.07 | $0.25 | ||
| Q4 24 | $-0.06 | $-0.02 | ||
| Q3 24 | $-0.33 | $0.23 | ||
| Q2 24 | $-0.02 | $0.07 | ||
| Q1 24 | $-0.50 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $115.5M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $183.9M | $161.6M |
| Total Assets | $444.4M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $115.5M | $93.9M | ||
| Q3 25 | $143.0M | $95.6M | ||
| Q2 25 | $136.3M | $81.3M | ||
| Q1 25 | $136.8M | $86.5M | ||
| Q4 24 | $145.5M | $84.7M | ||
| Q3 24 | $151.4M | $78.7M | ||
| Q2 24 | $92.9M | $68.7M | ||
| Q1 24 | $91.5M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $183.9M | $161.6M | ||
| Q3 25 | $115.1M | $166.7M | ||
| Q2 25 | $137.6M | $163.7M | ||
| Q1 25 | $158.2M | $167.1M | ||
| Q4 24 | $162.2M | $161.0M | ||
| Q3 24 | $173.6M | $162.6M | ||
| Q2 24 | $196.9M | $156.4M | ||
| Q1 24 | $195.1M | $159.7M |
| Q4 25 | $444.4M | $261.1M | ||
| Q3 25 | $480.6M | $264.8M | ||
| Q2 25 | $489.0M | $254.9M | ||
| Q1 25 | $493.9M | $252.7M | ||
| Q4 24 | $493.9M | $240.9M | ||
| Q3 24 | $502.7M | $245.3M | ||
| Q2 24 | $463.9M | $235.8M | ||
| Q1 24 | $461.1M | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.4M | $9.9M |
| Free Cash FlowOCF − Capex | $-14.7M | $7.6M |
| FCF MarginFCF / Revenue | -6.0% | 6.1% |
| Capex IntensityCapex / Revenue | 0.1% | 1.9% |
| Cash ConversionOCF / Net Profit | -0.21× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-17.2M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.4M | $9.9M | ||
| Q3 25 | $5.5M | $18.5M | ||
| Q2 25 | $642.0K | $4.3M | ||
| Q1 25 | $-5.6M | $2.6M | ||
| Q4 24 | $-9.0M | $12.2M | ||
| Q3 24 | $9.0M | $9.6M | ||
| Q2 24 | $1.3M | $1.3M | ||
| Q1 24 | $-27.3M | $2.2M |
| Q4 25 | $-14.7M | $7.6M | ||
| Q3 25 | $4.7M | $16.8M | ||
| Q2 25 | $-575.0K | $3.0M | ||
| Q1 25 | $-6.7M | $1.5M | ||
| Q4 24 | $-10.2M | $10.0M | ||
| Q3 24 | $7.7M | $7.9M | ||
| Q2 24 | $432.0K | $-2.0M | ||
| Q1 24 | $-29.4M | $-1.5M |
| Q4 25 | -6.0% | 6.1% | ||
| Q3 25 | 1.8% | 13.1% | ||
| Q2 25 | -0.2% | 2.6% | ||
| Q1 25 | -2.6% | 1.3% | ||
| Q4 24 | -4.2% | 8.5% | ||
| Q3 24 | 2.9% | 6.9% | ||
| Q2 24 | 0.2% | -1.9% | ||
| Q1 24 | -14.7% | -1.4% |
| Q4 25 | 0.1% | 1.9% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.4% | 1.2% | ||
| Q1 25 | 0.4% | 1.0% | ||
| Q4 24 | 0.5% | 1.9% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.3% | 3.0% | ||
| Q1 24 | 1.0% | 3.3% |
| Q4 25 | -0.21× | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOUG
| Commissions And Other Brokerage Income | $240.3M | 98% |
| Property Management Income | $2.8M | 1% |
| Property Management | $2.2M | 1% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
